Wry & Dry #9-25 Stagflation? Glasgow and Chairman Dan. Meanwhile, in Canada…
Rather like a nervous gambler who bet the house and is waiting for the Tattslotto numbers to drop on a Saturday night, Treasurer Grim Jim waited at his open office window for Wendy-the-carrier-pigeon to bring the GDP news from the Bureau of Statistics.
Grim Jim was relieved as he unfurled the paper from Wendy’s leg, and read a barely positive figure of 0.2% for the June quarter. “Still, better than a negative,” he muttered. Now, the task was to claim credit. Which, as a politician, he did.
Profit Reporting Season Concludes – Steadfast, Johns Lyng, Healius/ACL and Bapcore
This week, the Q2 ABS National Accounts data were released on Wednesday. Although a little backward-looking, the National Accounts can provide corroborative evidence of the trends we see from the company reporting season.
In this week’s Investment Matters, we will briefly discuss interesting trends from the reporting season and outline the results for Steadfast Group (SDF), Bapcor Group (BAP), and the new portfolio positions in Healius (HLS) and Australian Clinical Labs (ACL).